PLK1 and breast carcinoma: In the present study the treatmnet of MCF7 cell treated with the CU (200–500 μL) fraction for 24 h and significantly down regulation of the CDK1, CDC25A and PLK1 which is involved in cell cycle, and responsible for cell cycle arrest in tumour cells of breast cancer.